TLR2 and myocardial infarction: Treatment with β-caryophyllene in both doses significantly (p < 0.05) decreased TLR2 expression compared to the myocardial infarction group, measuring 4.51 and 3.28 vs. 7.00, respectively, as shown in Figure 5A. Additionally, treatment with β-caryophyllene significantly (p < 0.05) diminished TLR4 expression compared to the ischemic group, measuring 4.65 and 3.18 vs. 6.5, respectively (Figure 6B).